troglitazone has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 13 (68.42) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Libby, P; Marx, N; Murphy, C; Plutzky, J; Sukhova, G | 1 |
| Aaltonen, LA; de la Chapelle, A; Eng, C; Kum, JB; Mueller, E; Sarraf, P; Smith, WM; Spiegelman, BM; Wright, HM | 1 |
| Asano, M; Chisaki, K; Imuta, H; Iwasawa, K; Morita, T; Nakajima, T; Nakamura, F; Okuda, Y; Omata, M; Yamada, N | 1 |
| Arima, S; Igarashi, K; Ikeda, Y; Ito, S; Sugawara, A; Takeuchi, K; Taniyama, Y; Uruno, A | 1 |
| Abe, I; Eto, K; Fujishima, M; Nakamura, Y; Ohya, Y | 1 |
| Bécuwe, P; Bianchi, A; Bordji, K; Boyault, S; Dauça, M; Gouze, E; Netter, P; Simonin, MA; Terlain, B | 1 |
| Barrera, G; Briatore, F; Dianzani, MU; Ferretti, C; Laurora, S; Pizzimenti, S | 1 |
| Marx, N | 1 |
| Hiwada, K; Kitami, Y; Nakamura, M; Okura, T; Takata, Y; Yang, ZH | 1 |
| Greenberg, AS; Mathys, JM; Rabbi, MF; Skolnik, PR | 1 |
| Atkins, KB; Brosius, FC; Northcott, CA; Watts, SW | 1 |
| Chen, N; Liu, F; Wang, WM | 1 |
| He, Y; Huang, M; Huang, RW; Li, XD; Lin, DJ; Liu, JJ; Liu, PQ; Xiao, RZ | 1 |
| Buechler, C; Neumeier, M; Schäffler, A; Schölmerich, J; Weigert, J | 1 |
| Farrar, WL; Wang, LH; Yang, XY; Zhang, X | 1 |
| Keshamouni, VG; Milam, JE; Narala, VR; Newstead, MW; Reddy, RC; Standiford, TJ | 1 |
| Liao, K; Xiao, Y; Yao, W; Yuan, T | 1 |
| Fujimori, K; Kamauchi, S; Maruyama, T; Urade, Y | 1 |
| Hindman, HB; Huxlin, KR; Jeon, KI; Kulkarni, A; Phipps, RP; Sime, PJ; Woeller, CF | 1 |
19 other study(ies) available for troglitazone and 9-deoxy-delta-9-prostaglandin d2
| Article | Year |
|---|---|
Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.
Topics: Arteriosclerosis; Blotting, Northern; Blotting, Western; Cell Line; Cells, Cultured; Chromans; Collagenases; Humans; Immunoenzyme Techniques; Macrophages; Matrix Metalloproteinase 9; Monocytes; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1998 |
Loss-of-function mutations in PPAR gamma associated with human colon cancer.
Topics: Amino Acid Substitution; Binding Sites; Chromans; Colorectal Neoplasms; Dimerization; DNA-Binding Proteins; Exons; Genes, Tumor Suppressor; Humans; Hydroxyeicosatetraenoic Acids; Ligands; Linoleic Acids; Linoleic Acids, Conjugated; Mutation; Prostaglandin D2; Protein Binding; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone | 1999 |
Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
Topics: Animals; Calcium; Calcium Channels, L-Type; Cell Division; Cell Line; Chromans; Hypoglycemic Agents; Membrane Potentials; Muscle, Smooth, Vascular; Pioglitazone; Platelet-Derived Growth Factor; Prostaglandin D2; Rats; Thiazoles; Thiazolidinediones; Troglitazone; Vasopressins | 1999 |
Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2.
Topics: Animals; Base Sequence; Binding Sites; Chromans; Cloning, Molecular; DNA-Binding Proteins; Gene Expression Regulation, Enzymologic; Hypoglycemic Agents; Leucine Zippers; Macrophages; Molecular Sequence Data; NF-E2-Related Factor 2; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Thiazoles; Thiazolidinediones; Thromboxane-A Synthase; Trans-Activators; Transcription Factors; Transcription, Genetic; Troglitazone | 2000 |
Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle.
Topics: Analysis of Variance; Animals; Barium; Calcium; Chromans; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; Humans; Insulin Resistance; Ion Channels; Isoxazoles; Membrane Potentials; Muscle, Smooth, Vascular; Pioglitazone; Potassium Channels; Prostaglandin D2; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chromans; Cyclooxygenase 2; Fibroblasts; Gene Expression; Interleukin-1; Isoenzymes; Ligands; Lipopolysaccharides; Male; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Synovial Membrane; Thiazoles; Thiazolidinediones; Transcription Factor AP-1; Transcription Factors; Troglitazone; Tumor Necrosis Factor-alpha | 2002 |
Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation.
Topics: Aldehydes; Cell Differentiation; Cell Division; Chromans; Clofibrate; Clofibric Acid; Drug Synergism; Fibric Acids; HL-60 Cells; Humans; Ligands; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; U937 Cells | 2002 |
PPARgamma and vascular inflammation: adding another piece to the puzzle.
Topics: Animals; CCAAT-Enhancer-Binding Protein-delta; CCAAT-Enhancer-Binding Proteins; Cells, Cultured; Chromans; DNA-Binding Proteins; Gene Expression Regulation; Inflammation; Luciferases; Muscle, Smooth, Vascular; NF-kappa B; Phosphorylation; Prostaglandin D2; Protein Binding; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; STAT3 Transcription Factor; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Troglitazone | 2002 |
Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.
Topics: Animals; Carotid Arteries; CCAAT-Enhancer-Binding Protein-delta; CCAAT-Enhancer-Binding Proteins; Cells, Cultured; Chromans; DNA-Binding Proteins; Gene Expression Regulation; Inflammation; Interleukin-6; Luciferases; Male; Muscle, Smooth, Vascular; NF-kappa B; Phosphorylation; Prostaglandin D2; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; STAT3 Transcription Factor; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcription, Genetic; Troglitazone | 2002 |
Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cell Line; Chromans; Fenofibrate; HIV-1; Humans; Leukocytes, Mononuclear; Macrophages, Alveolar; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Necrosis Factor-alpha; Virus Replication | 2002 |
Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries.
Topics: Animals; Aorta; Arteries; Biomarkers; Blood Pressure; Carotid Arteries; Chromans; Deoxyglucose; Desoxycorticosterone; Glucose Transporter Type 4; Hypertension; Ligands; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Smooth, Vascular; PPAR gamma; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sodium Chloride; Thiazolidinediones; Troglitazone | 2005 |
[Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Topics: Animals; Blotting, Far-Western; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibroblasts; Fibronectins; Kidney; Peroxisome Proliferator-Activated Receptors; Prostaglandin D2; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2006 |
Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
Topics: Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Chromans; Cyclooxygenase 2; DNA, Neoplasm; Flow Cytometry; Gene Expression; Humans; Leukemia; Membrane Potential, Mitochondrial; Monocytes; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones; Thymidine; Troglitazone; U937 Cells | 2007 |
Regulation and function of collagenous repeat containing sequence of 26-kDa protein gene product "cartonectin".
Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Adiponectin; Animals; Cell Differentiation; Chromans; Fenofibrate; Gene Expression Regulation; Mice; Peroxisome Proliferator-Activated Receptors; Prostaglandin D2; Proteins; Resistin; RNA, Messenger; Thiazolidinediones; Troglitazone | 2007 |
Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP.
Topics: Bone Marrow; CCAAT-Enhancer-Binding Proteins; Cell Adhesion; Cell Line, Tumor; Cells, Cultured; Chromans; Humans; Multiple Myeloma; NF-kappa B; PPAR gamma; Prostaglandin D2; Receptor Cross-Talk; Stromal Cells; Thiazolidinediones; Troglitazone | 2007 |
Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}.
Topics: Actins; Anilides; Animals; Antineoplastic Agents; Cell Adhesion; Chemotaxis; Chromans; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fibrinogen; HL-60 Cells; Humans; Inflammation; Interleukin-4; Interleukin-8; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; N-Formylmethionine Leucyl-Phenylalanine; PPAR gamma; Prostaglandin D2; Sepsis; Thiazolidinediones; Troglitazone; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Apoptosis; bcl-Associated Death Protein; Caspase 3; Chromans; Male; Mice; Pioglitazone; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Zucker; Thiazolidinediones; Troglitazone | 2010 |
Activation of adipogenesis by lipocalin-type prostaglandin D synthase-generated Δ¹²-PGJ₂ acting through PPARγ-dependent and independent pathways.
Topics: 3T3-L1 Cells; Adipogenesis; Anilides; Animals; Chromans; Gene Expression Regulation; HeLa Cells; Humans; Hypoglycemic Agents; Intramolecular Oxidoreductases; Lipocalins; Mice; PPAR gamma; Prostaglandin D2; Thiazolidinediones; Troglitazone | 2012 |
Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.
Topics: Actins; Animals; Cats; Cell Line, Transformed; Cell Nucleus; Chromans; Collagen Type I; Cornea; Fibronectins; Fibrosis; Humans; Ligands; Myofibroblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Prostaglandin D2; Protein Kinase Inhibitors; Protein Transport; Rosiglitazone; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta1; Troglitazone; Wound Healing | 2014 |